Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Mattie R Nester

Researcher

UAMS

Unknown Researcher

1 h-index 4 pubs 3 cited

Research Areas

Biomedical Subjects

  • Receptor, Notch3
  • Multiple Myeloma
  • Drug Resistance, Neoplasm
  • Animals
  • Antineoplastic Agents
  • Disease Models, Animal
  • Humans
  • Signal Transduction
  • Xenograft Model Antitumor Assays
  • Cell Line, Tumor
  • Mice

OverviewAI-generated summary

Mattie R. Nester's research focuses on understanding and targeting mechanisms that contribute to drug resistance and dormancy in multiple myeloma. This work investigates the role of the NOTCH3 receptor as a potential therapeutic target for eradicating therapy-resistant and dormant multiple myeloma cells. Additionally, Nester's work explores methods to heal lytic bone lesions and restore bone health in multiple myeloma patients through the inhibition of sclerostin. Collaborations include Aric Anloague, Corey Montgomery, Corey O. Montgomery, and Hayley M. Sabol, all from the University of Arkansas for Medical Sciences, with whom Nester has co-authored multiple publications. Nester's scholarly output includes four publications and has garnered one citation, with an h-index of 1.

Metrics

  • h-index: 1
  • Publications: 4
  • Citations: 3

Selected Publications

  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Figshare DOI OpenAlex
  • Additional file 1 of Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Open MIND DOI OpenAlex
  • Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cells (2026)
    Journal of Experimental & Clinical Cancer Research DOI OpenAlex
  • Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition (2025)
    Experimental Hematology and Oncology 3 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

42 Collaborators 9 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics

Hayley M. Sabol University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Drug Transport and Resistance Mechanisms Receptor Mechanisms and Signaling
Strong match 5 shared topics
Delgado-Calle Jesus University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Drug Transport and Resistance Mechanisms Receptor Mechanisms and Signaling
Good match 4 shared topics
Bethany C. Paxton University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Drug Transport and Resistance Mechanisms Receptor Mechanisms and Signaling
Good match 4 shared topics
Monica Graziutti University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Receptor Mechanisms and Signaling Cancer Treatment and Pharmacology
Good match 3 shared topics
Scott A. Stuart University of Arkansas for Medical Sciences
Drug Transport and Resistance Mechanisms Bone health and treatments Cancer Treatment and Pharmacology
Good match 3 shared topics
Asis Shrestha University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments Drug Transport and Resistance Mechanisms Cancer Treatment and Pharmacology
Good match 3 shared topics